ARTICLE
|
doi:10.20944/preprints202312.0594.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
neuromyelitis optica disorder; anti-aquaporin-4; anti-myelin oligodendrocyte glycoprotein; rituximab; serious infection
Online: 8 December 2023 (09:59:09 CET)
CASE REPORT
|
doi:10.20944/preprints202401.0224.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Neuromyelitis optica spectrum disorder (NMOSD); Aquaporin proteins; AQP4 and AQP1; longitudinally extensive transverse myelitis (LETM); Area Postrema Syndrome
Online: 3 January 2024 (09:43:18 CET)
REVIEW
|
doi:10.20944/preprints202305.0940.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
multiple sclerosis; neuromyelitis optica spectrum disorders; genetic basis; inflammatory demyelinating disease; genes
Online: 12 May 2023 (11:23:13 CEST)
INTERESTING IMAGES
|
doi:10.20944/preprints202311.0542.v1
Subject:
Medicine And Pharmacology,
Orthopedics And Sports Medicine
Keywords:
neuromyelitis optica; cervical spondylotic myelopathty; neuroimaging; anti-aquaporin4 antibody)
Online: 8 November 2023 (10:45:44 CET)
ARTICLE
|
doi:10.20944/preprints202405.0632.v1
Subject:
Public Health And Healthcare,
Public Health And Health Services
Keywords:
neuromyelitis optica; measure cost; Unified Health System.
Online: 10 May 2024 (10:38:31 CEST)
ARTICLE
|
doi:10.20944/preprints202012.0705.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
Rituximab; Multiple Sclerosis; Neuromyelitis Optica; demyelinating diseases
Online: 28 December 2020 (13:22:04 CET)
REVIEW
|
doi:10.20944/preprints202408.1175.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
blood-brain barrier; neuroimmunological disease; multiple sclerosis; neuromyelitis optica spectrum disorder; autoimmune encephalitis; paraneoplastic neurological syndrome
Online: 20 August 2024 (04:08:59 CEST)
ARTICLE
|
doi:10.20944/preprints202402.0500.v1
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
Acute disseminated encephalomyelitis; Central nervous system inflammatory demyelinating diseases; COVID-19 vaccines; Myelin oligodendrocyte glycoprotein antibody-associated disease; Neuromyelitis optica spectrum disorders; Transverse myelitis
Online: 8 February 2024 (08:43:50 CET)